In fact, antibacterial activities against oral pathogens have been demonstrated for statherin and its C-terminal fragments [77], which retain the specific binding sites for Porphyromonas gingivalis, the keystone pathogen in periodontitis [78]. The gene discussed is STATH; the disease is periodontitis.